During the secondary analysis, the a lot less conservative but clinically meaningful criterion of secure response (defined being a 50% or more reduction in MADRS from baseline for 2 months) was used. From the patients who accomplished stable reaction, 25.8% within the esketamine group and fifty seven.six% from the placebo https://ryszardw222vky0.lotrlegendswiki.com/user